期刊文献+

水痘-带状疱疹病毒糖蛋白E的纯化及鉴定 被引量:2

Purification and Identification of Recombinant Varicella-Zoster Virus Glycoprotein E
下载PDF
导出
摘要 目的 纯化及鉴定重组表达的水痘 -带状疱疹病毒 (VZV)糖蛋白 E(g E)。方法 用 IPTG诱导重组载体 p GEX- VZVg E表达融合蛋白 ,并用亲和层析纯化融合蛋白 ;然后用凝血酶酶切融合蛋白 ,并用免疫印迹法检测酶切产物的抗原性。结果  p GEX- VZVg E的 IPTG诱导表达产物用亲和层析柱去除杂蛋白后 ,获得相对分子质量为 98× 10 3的纯化融合蛋白 ,经凝血酶酶切后得到了相对分子质量大约为 72× 10 3的糖蛋白 E;纯化的融合蛋白和糖蛋白 E均为 SDS- PAGE单点纯 ,并用免疫印迹证明糖蛋白 E具有良好的抗原性。结论 采用亲和层析柱可以有效的纯化重组 VZV糖蛋白 E,从而为 VZV糖蛋白 E的应用研究打下了基础。 Objective To purify and identify recombinant Varicella-Zoster Virus Glycoprotein E. Methods The recombinant plasmid pGEX-VZVgE was induced by isopropy-β-D-thiogalactoside(IPTG), the fusion protein was purified with affinity chromatography column; then the purified fusion protein was cleaved by thrombin, and the product's antigenicity was examined by Western blot. Results The product of pGEX-VZVgE induced by IPTG was separated from the mixture proteins by the affinity chromatography column, the expressed fusion protein's relative molecular mass was about 98×10 3. After cleavage, the obtained VZV Glycoprotein E's relative molecular mass was about 72×10 3; the purified fusion protein and VZV Glycoprotein E were single band by SDS-PAGE; The available antigenicity of Glycoprotein E was confirmed by Western blot.Conclusion Purification of VZV Glycoprotein E with affinity chromatography is an effective method. It provides a foreground for studies on the application of VZV gE.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2005年第2期281-283,共3页 Journal of Sichuan University(Medical Sciences)
关键词 水痘-带状疱疹病毒 糖蛋白E融合蛋白 亲和层析 免疫印迹 Varicella-zoster virus Glycoprotein E Fusion protein Affinity chromatography Western blot
  • 相关文献

参考文献11

  • 1Arvin AM. Varicella-zoster virus. In: Fields BN, Knipe DM,Howley PM, editors. Fields Virology. 3rd edition.Philadelphia: Lippincott-Raven, 1996:2547 - 2548.
  • 2Garcia Valcarcel M, Fowler WJ, Harper DR, et al. Induction of neutralizing antibody and T cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoproteinE (gE). Vaccine,1997;15(5-6):709.
  • 3Hasan UA, Abai A, Harper DR, et al. Nucleic acid immunization: concepts and techniques associated with third generation vaccines. J Immunol Methods, 1999;229(1):1.
  • 4Hasan UA, Harper DR, Argent S, et al. Immunization with DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes. Vaccine ,2000; 18(11 - 12): 1505.
  • 5Arvin AM, Mallory S, Moffat JF. Development of recombinant varicella-zoster virus vaccines. Contrib Microbiol,1999;3(2):193.
  • 6Jacquet A, Haumont M, Massaer M, et al. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation. Vaccine, 2002;20(11 - 12):1593.
  • 7Stasikova J, Kutinova L, Smahel M, et al. Immunization with Varicella-zoster virus glycoprotein E expressing vectors:Comparison of antibody response to DNA vaccine and recombinant vaccinia virus. Acta Virol, 2003; 47 (1): 1.
  • 8Hasan UA, Harper DR, Wren BW, et al. Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E. Vaccine,2002;20(9 - 10):1308.
  • 9Caleo M, Menna E, Chierzi S, et al. Brain-derived neurotrophic factor is an anterograde survival factor in the rat visual system. Curr Biol,2000;10(6):1155.
  • 10Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene,1988;67(1):31.

同被引文献18

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部